Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) is the most common form of liver pathologies and is associated with obesity and the metabolic syndrome, which represents a range of fatty liver diseases associated with an increased risk of type 2 diabetes. Molecular mechanisms underlying how to make transition from simple fatty liver to nonalcoholic steatohepatitis (NASH) are not well understood. However, accumulating evidence indicates that deregulation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway in hepatocytes is a common molecular event associated with metabolic dysfunctions including obesity, metabolic syndrome, and the NAFLD. A tumor suppressor PTEN negatively regulates the PI3K/AKT pathways through its lipid phosphatase activity. Molecular studies in the NAFLD support a key role for PTEN in hepatic insulin sensitivity and the development of steatosis, steatohepatitis, and fibrosis. We review recent studies on the features of the PTEN and the PI3K/AKT pathway and discuss the protein functions in the signaling pathways involved in the NAFLD. The molecular mechanisms contributing to the diseases are the subject of considerable investigation, as a better understanding of the pathogenesis will lead to novel therapies for a condition.

• Publication year

  2013

• Venue

  ISRN Endocrinology

• Publication date

  2013-01-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2013/472432PMID 23431468PMCID 3570922
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development

  2013cited by this paper
• GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

  2012cited by this paper
• Critical role of hypoxia sensor--HIF-1α in VEGF gene activation. Implications for angiogenesis and tissue injury healing.

  2012cited by this paper
• Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach

  2012influential reference
• PI3K/AKT/PTEN Signaling as a Molecular Target in Leukemia Angiogenesis

  2012cited by this paper
• Guanosine protects human neuroblastoma SH-SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via PI3K/Akt/GSK-3β pathway.

  2012cited by this paper
• mTORC1 signaling and regulation of pancreatic β-cell mass

  2012cited by this paper
• Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

  2012influential reference
• Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.

  2012cited by this paper
• Liver-specific p70 S6 Kinase Depletion Protects against Hepatic Steatosis and Systemic Insulin Resistance*

  2012cited by this paper
• The functions and regulation of the PTEN tumour suppressor

  2012cited by this paper
• NAFLD in the Absence of Metabolic Syndrome: Different Epidemiology, Pathogenetic Mechanisms, Risk Factors for Disease Progression?

  2012influential reference
• Endogenous viruses: insights into viral evolution and impact on host biology

  2012cited by this paper
• Mitochondrial dysfunction and antioxidant therapy in sepsis.

  2012cited by this paper
• Analysis of adipokine concentrations in paediatric non‐alcoholic fatty liver disease

  2012cited by this paper
• Targeting PI3 kinase/AKT/mTOR signaling in cancer.

  2012cited by this paper
• Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.

  2012influential reference
• Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance.

  2012cited by this paper
• Mitochondrial Reactive Oxygen Species and Risk of Atherosclerosis

  2012cited by this paper
• Mitochondrial ROS generation for regulation of autophagic pathways in cancer.

  2011cited by this paper
• Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

  2011influential reference
• Non-alcoholic fatty liver disease

  2011cited by this paper
• The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival.

  2011cited by this paper
• ETHANOL EXTRACT OF ROSEMARY REPRESSED PTEN EXPRESSION IN K562 CULTURE CELLS.

  2011cited by this paper
• Molecular mechanisms of steatosis in nonalcoholic fatty liver disease.

  2011cited by this paper
• Progesterone Receptor-B Induction of BIRC3 Protects Endometrial Cancer Cells from AP1-59-Mediated Apoptosis

  2011cited by this paper
• Melatonin alleviates lipopolysaccharide‐induced hepatic SREBP‐1c activation and lipid accumulation in mice

  2011cited by this paper
• Role of ezetimibe in non-alcoholic fatty liver disease.

  2011cited by this paper
• The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.

  2011cited by this paper
• ROS acts as a double-edged sword in the pathogenesis of type 2 diabetes mellitus: is Nrf2 a potential target for the treatment?

  2011cited by this paper
• Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities

  2011cited by this paper
• The PI3K-Akt pathway inhibits senescence and promotes self-renewal of human skin-derived precursors in vitro

  2011cited by this paper
• Oxidative stress, insulin signaling, and diabetes.

  2011cited by this paper
• Metabolic therapy: lessons from liver diseases.

  2011cited by this paper
• Differing effects of rapamycin and mTOR kinase inhibitors on protein synthesis.

  2011cited by this paper
• Akt signalling in health and disease.

  2011cited by this paper
• Post-translational modifications of PTEN and their potential therapeutic implications.

  2011cited by this paper
• PTEN in Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis and Cancer

  2010cited by this paper
• PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.

  2010cited by this paper
• Deletion of Pten in Pancreatic β-Cells Protects Against Deficient β-Cell Mass and Function in Mouse Models of Type 2 Diabetes

  2010cited by this paper
• Bile Acids as Regulators of Hepatic Lipid and Glucose Metabolism

  2010cited by this paper
• Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN.

  2010influential reference
• PI3K signaling in neutrophils.

  2010cited by this paper
• Updates of mTOR inhibitors.

  2010cited by this paper
• Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4

  2010cited by this paper
• Proceedings of the Australian Physiological Society Symposium: Role of ROS in Cardiovascular Function and Disease Reactive oxygen species and insulin-resistant cardiomyopathy

  2010cited by this paper
• A Versatile Role of Mammalian Target of Rapamycin in Human Dendritic Cell Function and Differentiation

  2010cited by this paper
• Shiga Toxin 1-Induced Proinflammatory Cytokine Production Is Regulated by the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway

  2009cited by this paper
• Induction of gene encoding FABP4 in Pten‐null keratinocytes

  2009cited by this paper
• Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.

  2009cited by this paper
• Hypoxia and non-alcoholic fatty liver disease.

  2009cited by this paper
• Cigarette smoke exposure: a novel cofactor of NAFLD progression?

  2009cited by this paper
• High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo

  2008cited by this paper
• RNAi-mediated chromatin silencing in fission yeast.

  2008cited by this paper
• Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation.

  2008cited by this paper
• The PI3K/Akt/mTOR pathway in innate immune cells: emerging therapeutic applications

  2008cited by this paper
• PTEN and GSK3beta: key regulators of progression to androgen-independent prostate cancer.

  2006cited by this paper
• Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity

  2006cited by this paper
• Selective Deletion of Pten in Pancreatic β Cells Leads to Increased Islet Mass and Resistance to STZ-Induced Diabetes

  2006cited by this paper
• Effects of Sex and Insulin/Insulin-Like Growth Factor-1 Signaling on Performance in an Associative Learning Paradigm in Caenorhabditis elegans

  2006cited by this paper
• PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer

  2006cited by this paper
• PTEN, but Not SHIP2, Suppresses Insulin Signaling through the Phosphatidylinositol 3-Kinase/Akt Pathway in 3T3-L1 Adipocytes*

  2005cited by this paper
• A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells.

  2005cited by this paper
• Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma.

  2005influential reference
• Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity

  2004cited by this paper
• Increase of PTEN gene expression in insulin resistance.

  2004cited by this paper
• Akt-mediated Cardiomyocyte Survival Pathways Are Compromised by Gαq-induced Phosphoinositide 4,5-Bisphosphate Depletion*

  2003cited by this paper
• Rhebbing up mTOR: New Insights on TSC1 and TSC2, and the Pathogenesis of Tuberous Sclerosis

  2003cited by this paper
• Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.

  2001cited by this paper
• PDK2: A Complex Tail in One Akt

  2001cited by this paper
• The Tumor Suppressor PTEN Negatively Regulates Insulin Signaling in 3T3-L1 Adipocytes*

  2000cited by this paper

• Critical Roles and Molecular Mechanisms of Chaperone-Mediated Autophagy in Infections

  2026cites this paper
• Renalase deficiency suppresses hepatic triglyceride accumulation in the progression to MASLD/MASH by GAN diet in male mice

  2026cites this paper
• Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats

  2025cites this paper
• Linking bisphenol a exposure to MASLD: insights from network toxicology and machine learning based on NHANES 2005–2012 data

  2025cites this paper
• Enteromorpha Polysaccharides Alleviate High-Fat Diet-Induced Glucolipid Metabolism Disorders via the K18-Mediated IRS-1/PI3K/AKT/GSK3β Pathway.

  2025cites this paper
• Assessing the therapeutic potential of Tirzepatide in modulating inflammatory responses and mitigating acute pancreatitis

  2025cites this paper
• DC09, Derivative of 3‐(2‐hydroxy‐5‐methoxyphenyl)‐1‐(5‐methylfuran‐2‐yl)prop‐2‐en‐1‐one Attenuates Nonalcoholic Fatty Liver Disease by Targeting PI3K/Akt Pathway: Insights From In‐Vivo Zebrafish Model and In‐Vitro HepG2 Cell

  2025cites this paper
• Exploring drug repurposing as a therapeutic strategy for non-alcoholic fatty liver disease (NAFLD): identification of potential targets and pathways

  2025cites this paper
• Circular RNAs in Liver Diseases.

  2025cites this paper
• Mitophagy as a pivotal axis in non-alcoholic fatty liver disease: From pathogenic mechanisms to therapeutic strategies (Review)

  2025cites this paper
• Identification of foam cell like M2 macrophages, AEBP1 biomarkers, and resveratrol as potential therapeutic in MASLD using Ecotyper and WGCNA

  2025cites this paper
• Hepato-Renal Crosstalk in Acute and Chronic Disease: From Shared Pathways to Therapeutic Targets

  2025cites this paper
• Integrated metabolomics and network pharmacology reveal the PI3K/Akt-mediated therapeutic mechanism of Abrus cantoniensis in lipid metabolism disorders.

  2025cites this paper
• Multi-omics insights into 6PPD- and 6PPDQ-induced gut-liver axis disruption and non-alcoholic fatty liver disease progression in zebrafish (Danio rerio).

  2025cites this paper
• Synergistic salvation: HIIT and herbal allies reverse NAFLD damage in rats

  2025cites this paper
• BRCA1 regulates glucose and lipid metabolism in diabetes mellitus with metabolic dysfunction-associated steatotic liver disease via the PI3K/Akt signaling pathway

  2025cites this paper
• Hyperinsulinemic male LEW.1WR1 rats show early signs of impaired liver metabolism

  2025cites this paper
• Hepatic adverse events associated with anaplastic lymphoma kinase tyrosine kinase inhibitors: a disproportionality analysis based on FAERS Database and analysis of drug-gene interaction network.

  2025cites this paper
• Molecular Clustering of Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Transcriptome Analysis

  2025cites this paper
• Exploring shared molecular signatures and regulatory mechanisms in nonalcoholic steatohepatitis and inflammatory bowel disease using integrative bioinformatics analysis

  2024cites this paper
• Signal transductions and nonalcoholic fatty liver

  2024cites this paper
• Cholesterol overload in macrophages drives metabolic dysfunction-associated steatohepatitis via inhibiting 7-dehydrocholesterol reductase in mice

  2024cites this paper
• Chickpea (Cicer arietinum) protein hydrolysate ameliorates metabolic effects of feeding a high-fat diet to mice

  2024cites this paper
• Mechanism investigation of anti-NAFLD of Shugan Yipi Granule based on network pharmacology analysis and experimental verification

  2024cites this paper
• Transitions in chromatin conformation shaped by fatty acids and the circadian clock underlie hepatic transcriptional reorganization in obese mice

  2024cites this paper
• Exploring the mechanism of dendrobine in treating metabolic associated fatty liver disease based on network pharmacology and experimental validation

  2024cites this paper
• Therapeutic potential and pharmacological mechanism of visnagin.

  2024cites this paper
• Inhibition of Pim kinases triggers a broad antiviral activity by affecting innate immunity and via the PI3K-Akt-mTOR axis the endolysosomal system.

  2024cites this paper
• Ketogenic diet and beta-hydroxybutyrate modulate the hepatic expression of AKT/PI3K/mTOR pathway during treatment of obesity in rats.

  2024cites this paper
• Network pharmacological analysis on the mechanism of Linggui Zhugan decoction for nonalcoholic fatty liver disease

  2024cites this paper
• PFHxS Exposure and the Risk of Non-Alcoholic Fatty Liver Disease

  2024cites this paper
• Targeting Protein Phosphatases for the Treatment of Chronic Liver Disease.

  2024cites this paper
• Efficacy of Ganshuang granules on non-alcoholic fatty liver and underlying mechanism: a network pharmacology and experimental verification.

  2024cites this paper
• Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats

  2023cites this paper
• Adjuvant therapy with Huatan Sanjie Granules improves the prognosis of patients with primary liver cancer: a cohort study and the investigation of its mechanism of action based on network pharmacology

  2023cites this paper
• Transcriptomic changes in liver transplant recipients with non-alcoholic steatohepatitis indicate dysregulation of wound healing

  2023influential citation
• The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study

  2023cites this paper
• Integrated omics analysis for characterization of the contribution of high fructose corn syrup to non-alcoholic fatty liver disease in obesity.

  2023cites this paper
• Targeted MicroRNA Profiling Reveals That Exendin-4 Modulates the Expression of Several MicroRNAs to Reduce Steatosis in HepG2 Cells

  2023cites this paper
• Coptidis rhizoma and evodiae fructus against lipid droplet deposition in nonalcoholic fatty liver disease‐related liver cancer by AKT

  2023cites this paper
• Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease: Epidemiology, Pathogenesis, and Clinical and Research Implications

  2022cites this paper
• The case for FAT10 as a novel target in fatty liver diseases

  2022cites this paper
• Inhibition of neuropilin-1 improves non-alcoholic fatty liver disease in high-fat-diet induced obese mouse.

  2022cites this paper
• Helminth infection and helminth-derived products: A novel therapeutic option for non-alcoholic fatty liver disease

  2022cites this paper
• Integrated strategy of RNA-sequencing and network pharmacology for exploring the protective mechanism of Shen-Shi-Jiang-Zhuo formula in rat with non-alcoholic fatty liver disease

  2022cites this paper
• mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Transcriptome changes in stages of non-alcoholic fatty liver disease

  2022cites this paper
• Multiomics analysis of the impact of polychlorinated biphenyls on environmental liver disease in a mouse model.

  2022cites this paper
• Modulation of endoplasmic reticulum stress via sulforaphane-mediated AMPK upregulation against nonalcoholic fatty liver disease in rats

  2022cites this paper
• Multiple Mechanisms of Shenqi Pill in Treating Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking

  2022cites this paper
• The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions.

  2022cites this paper
• Phytochemicals from the Cocoa Shell Modulate Mitochondrial Function, Lipid and Glucose Metabolism in Hepatocytes via Activation of FGF21/ERK, AKT, and mTOR Pathways

  2022cites this paper
• 3,5-T2-an Endogenous Thyroid Hormone Metabolite as Promising Lead Substance in Anti-Steatotic Drug Development?

  2022cites this paper
• Identification of the Potential Molecular Mechanisms Linking RUNX1 Activity with Nonalcoholic Fatty Liver Disease, by Means of Systems Biology

  2022cites this paper
• PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway.

  2022cites this paper
• System-level investigation of anti-obesity effects and the potential pathways of Cordyceps militaris in ovariectomized rats

  2022cites this paper
• Caffeine Ameliorates AKT-Driven Nonalcoholic Steatohepatitis by Suppressing De Novo Lipogenesis and MyD88 Palmitoylation.

  2022cites this paper
• Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19

  2022cites this paper
• MicroRNA-122-5p Inhibition Improves Inflammation and Oxidative Stress Damage in Dietary-Induced Non-alcoholic Fatty Liver Disease Through Targeting FOXO3

  2022cites this paper
• Activating Effects of the Bioactive Compounds From Coffee By-Products on FGF21 Signaling Modulate Hepatic Mitochondrial Bioenergetics and Energy Metabolism in vitro

  2022cites this paper
• Differential distribution of gene polymorphisms associated with hypercholesterolemia, hypertriglyceridemia, and hypoalphalipoproteinemia among Native American and Mestizo Mexicans

  2022cites this paper
• Serum miR-379 expression is related to the development and progression of 2 hypercholesterolemia in non-alcoholic fatty liver disease 3 4 Short title: Serum miR-379 relates hypercholesterolemia in NAFLD

  2022cites this paper
• Mechanisms of Cynarine for treatment of non-alcoholic fatty liver disease based on the integration of network pharmacology, molecular docking and cell experiment

  2022cites this paper
• Study on the Mechanism of Zhenwu Decoction in Decreasing the Fats in Non-Alcoholic Fatty Liver Disease Using System Pharmacology and Cytological Validation Test

  2022cites this paper
• Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation

  2022cites this paper
• Effect of Myricetin on Lipid Metabolism in Primary Calf Hepatocytes Challenged with Long-Chain Fatty Acids

  2022cites this paper
• Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling).

  2021cites this paper
• Degree Adjusted Large-Scale Network Analysis Reveals Novel Putative Metabolic Disease Genes

  2021influential citation
• RETRACTED: MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling

  2021cites this paper
• Insights into Molecular Mechanisms Underlying NAFLD by Protein-Protein Interaction Network Analysis of the Differentially Expressed Genes in NASH Patients.

  2021cites this paper
• Broccoli Florets Supplementation Improves Insulin Sensitivity and Alters Gut Microbiome Population—A Steatosis Mice Model Induced by High-Fat Diet

  2021cites this paper
• Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD

  2021cites this paper
• mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma

  2021cites this paper
• Phosphorylation of androgen receptor by mTORC1 promotes liver steatosis and tumorigenesis

  2021influential citation
• Phytotherapy as Multi-Hit Therapy to Confront the Multiple Pathophysiology in Non-Alcoholic Fatty Liver Disease: A Systematic Review of Experimental Interventions

  2021cites this paper
• Inhibition of Neuropilin-1 improves non-alcoholic fatty liver disease via PI3K/AKT/mTOR signaling in high-fat-diet induced obese mouse

  2021cites this paper
• Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease

  2021cites this paper
• Noncoding RNAs Interactions in Hepatic Stellate Cells during Hepatic Fibrosis

  2021cites this paper
• Construction and Analysis of Protein-Protein Interaction Network of Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Reveals Broad Alterations in Hepatic Lipid Composition in an Experimental Mouse Model of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• AdipoR1/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis

  2020cites this paper
• Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA-20a-mediated activation of the PTEN/PI3K/AKT signaling pathway

  2020cites this paper
• Angiotensin‐(1‐7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism

  2020cites this paper
• MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy

  2020cites this paper
• Identifying potential functional lncRNAs in metabolic syndrome by constructing a lncRNA–miRNA–mRNA network

  2020cites this paper
• Hepatic transcriptome signature correlated with HOMA-IR explains early Nonalcoholic Fatty Liver Disease pathogenesis.

  2020cites this paper
• Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice.

  2020cites this paper
• Bioinformatics analysis of the NAFLD Interactome: Revealing candidate biomarkers of Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• RETRACTED ARTICLE: Silencing of PTEN inhibits the oxidative stress damage and hippocampal cell apoptosis induced by Sevoflurane through activating MEK1/ERK signaling pathway in infant rats

  2020cites this paper
• Protective effects of morin against acrylamide-induced hepatotoxicity and nephrotoxicity: A multi-biomarker approach.

  2020cites this paper
• Phenols fragment of Veronica ciliata Fisch. Ameliorate free radical-induced nonalcoholic fatty liver disease by mediating PI3K/Akt signaling pathway.

  2020cites this paper
• The Metabolic Reprogramming Profiles in the Liver Fibrosis of Mice Infected with Schistosoma japonicum

  2020cites this paper
• Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro

  2020cites this paper
• The Combination of Mulberry Extracts and Silk Amino Acids Alleviated High Fat Diet-Induced Nonalcoholic Hepatic Steatosis by Improving Hepatic Insulin Signaling and Normalizing Gut Microbiome Dysbiosis in Rats

  2019cites this paper
• Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease

  2019cites this paper
• Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.

  2019cites this paper
• The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice

  2019cites this paper
• LncRNA-CASC7 enhances corticosteroid sensitivity via inhibiting the PI3K/AKT signaling pathway by targeting miR-21 in severe asthma.

  2019cites this paper
• Coenzyme Q10 protects hepatocytes from ischemia reperfusion-induced apoptosis and oxidative stress via regulation of Bax/Bcl-2/PUMA and Nrf-2/FOXO-3/Sirt-1 signaling pathways.

  2019cites this paper